Oncology PracticeImmunotherapy and Survival in Advanced NSCLC: Does Obesity Matter?August 12, 2024Lung CancerPatient & Survivor CareImmunotherapyImmuno-oncology
Hematology NewsFDA Approves Lymphir for R/R Cutaneous T-Cell LymphomaAugust 9, 2024T Cell LymphomasPatient & Survivor CareBusiness of MedicineImmunotherapyLymphoma & Plasma Cell DisordersImmuno-oncologyPractice Management
Oncology PracticeImmunotherapy May Be Overused in Dying Patients With CancerAugust 8, 2024ImmunotherapyImmuno-oncologyBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastroenterology
Oncology PracticeModest Gains Shown in Breast Cancer Immunotherapy TrialsAugust 8, 2024Breast CancerMetastatic Breast CancerPatient & Survivor CareImmunotherapyImmuno-oncology
Oncology PracticeFDA Approves First Engineered Cell Therapy for a Solid TumorAugust 2, 2024Sarcoma & GISTPatient & Survivor CareCNS/Brain CancerNeuro-oncologyNonmelanoma Skin CancerMetastatic Breast CancerPractice Management
Oncology PracticeIs Immunotherapy Best for Unresectable HCC with Moderate Liver Dysfunction?July 19, 2024Gastrointestinal CancerPatient & Survivor CareGastroenterologyImmunotherapyImmuno-oncology
Oncology PracticeMUC-1 vaccine associated with notable overall survival rates in breast cancerJune 27, 2024Breast CancerPatient & Survivor CareImmunotherapyImmuno-oncologyLung Cancer
Oncology PracticePruritic, violaceous papules in a patient with renal cell carcinomaJune 20, 2024Mixed TopicsRenal Cell CarcinomaImmunotherapy
Oncology PracticeChronotherapy: Why Timing Drugs to Our Body Clocks May WorkJune 10, 2024Immunotherapy
Oncology PracticeMerkel Cell: Immunotherapy Not Used for Many Patients With Metastatic DiseaseMay 22, 2024MelanomaNonmelanoma Skin CancerImmunotherapy
Oncology PracticeSurvey Spotlights Identification of Dermatologic Adverse Events From Cancer TherapiesMay 13, 2024Mixed TopicsBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
Oncology PracticeDo Patients Benefit from Cancer Trial Participation?May 8, 2024Patient & Survivor CareSarcoma & GISTRenal Cell CarcinomaNonmelanoma Skin CancerMetastatic Breast CancerMelanomaLung Cancer
Oncology PracticeFDA Approves New Bladder Cancer DrugApril 24, 2024Genitourinary CancerPatient & Survivor CarePractice ManagementImmunotherapy
Oncology PracticeMost Targeted Cancer Drugs Lack Substantial Clinical BenefitApril 17, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
